Global and China DTaP and Tdap Vaccines Market Insights, Forecast to 2026

List of Tables
Table 1. DTaP and Tdap Vaccines Market Segments
Table 2. Ranking of Global Top DTaP and Tdap Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global DTaP and Tdap Vaccines Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of DTaP
Table 5. Major Manufacturers of Td
Table 6. Major Manufacturers of Tdap
Table 7. Global DTaP and Tdap Vaccines Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global DTaP and Tdap Vaccines Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global DTaP and Tdap Vaccines Sales by Regions 2015-2020 (K Units)
Table 10. Global DTaP and Tdap Vaccines Sales Market Share by Regions (2015-2020)
Table 11. Global DTaP and Tdap Vaccines Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global DTaP and Tdap Vaccines Sales Forecast by Region (2021-2026) (K Units)
Table 13. Global DTaP and Tdap Vaccines Sales by Manufacturers (2015-2020) (K Units)
Table 14. Global DTaP and Tdap Vaccines Sales Share by Manufacturers (2015-2020)
Table 15. Global DTaP and Tdap Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global DTaP and Tdap Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in DTaP and Tdap Vaccines as of 2019)
Table 17. DTaP and Tdap Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. DTaP and Tdap Vaccines Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers DTaP and Tdap Vaccines Price (2015-2020) (USD/Unit)
Table 20. DTaP and Tdap Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers DTaP and Tdap Vaccines Product Type
Table 22. Date of International Manufacturers Enter into DTaP and Tdap Vaccines Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global DTaP and Tdap Vaccines Sales by Type (2015-2020) (K Units)
Table 25. Global DTaP and Tdap Vaccines Sales Share by Type (2015-2020)
Table 26. Global DTaP and Tdap Vaccines Revenue by Type (2015-2020) (US$ Million)
Table 27. Global DTaP and Tdap Vaccines Revenue Share by Type (2015-2020)
Table 28. DTaP and Tdap Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 29. Global DTaP and Tdap Vaccines Sales Share by Type (2021-2026)
Table 30. Global DTaP and Tdap Vaccines Sales by Application (2015-2020) (K Units)
Table 31. Global DTaP and Tdap Vaccines Sales Share by Application (2015-2020)
Table 32. Global DTaP and Tdap Vaccines Sales Share by Application (2021-2026)
Table 33. Global DTaP and Tdap Vaccines Sales Market Share Forecast by Application (2021-2026)
Table 34. Global DTaP and Tdap Vaccines Revenue by Application (2015-2020) (US$ Million)
Table 35. Global DTaP and Tdap Vaccines Revenue Market Share Forecast by Application (2021-2026)
Table 36. China DTaP and Tdap Vaccines Sales (K Units) of Key Companies (2015-2020)
Table 37. China DTaP and Tdap Vaccines Sales Share by Company (2015-2020)
Table 38. China DTaP and Tdap Vaccines Revenue (US$ Million) by Company (2015-2020)
Table 39. China DTaP and Tdap Vaccines Sales (K Units) by Type (2015-2020)
Table 40. China DTaP and Tdap Vaccines Sales Share by Type (2015-2020)
Table 41. China DTaP and Tdap Vaccines Revenue (US$ Million) Market Share by Type (2015-2020)
Table 42. China DTaP and Tdap Vaccines Price (K Units) by Type (2015-2020)
Table 43. China DTaP and Tdap Vaccines Sales (K Units) by Type (2021-2026)
Table 44. China DTaP and Tdap Vaccines Sales Share by Type (2021-2026)
Table 45. China DTaP and Tdap Vaccines Revenue (US$ Million) Market Share by Type (2021-2026)
Table 46. China DTaP and Tdap Vaccines Revenue Share by Type (2021-2026)
Table 47. China DTaP and Tdap Vaccines Price (K Units) by Type (2021-2026)
Table 48. China DTaP and Tdap Vaccines Sales (K Units) by Application (2015-2020)
Table 49. China DTaP and Tdap Vaccines Sales Share by Application (2015-2020)
Table 50. China DTaP and Tdap Vaccines Revenue (US$ Million) Market Share by Application (2015-2020)
Table 51. China DTaP and Tdap Vaccines Sales (K Units) by Application (2021-2026)
Table 52. China DTaP and Tdap Vaccines Sales Share by Application (2021-2026)
Table 53. China DTaP and Tdap Vaccines Revenue (US$ Million) Market Share by Application (2021-2026)
Table 54. China DTaP and Tdap Vaccines Revenue Share by Application (2021-2026)
Table 55. North America DTaP and Tdap Vaccines Sales by Country (2015-2020) (K Units)
Table 56. North America DTaP and Tdap Vaccines Sales Market Share by Country (2015-2020)
Table 57. North America DTaP and Tdap Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 58. North America DTaP and Tdap Vaccines Revenue Market Share by Country (2015-2020)
Table 59. Europe DTaP and Tdap Vaccines Sales by Country (2015-2020) (K Units)
Table 60. Europe DTaP and Tdap Vaccines Sales Market Share by Country (2015-2020)
Table 61. Europe DTaP and Tdap Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 62. Europe DTaP and Tdap Vaccines Revenue Market Share by Country (2015-2020)
Table 63. Asia Pacific DTaP and Tdap Vaccines Sales by Region (2015-2020) (K Units)
Table 64. Asia Pacific DTaP and Tdap Vaccines Sales Market Share by Region (2015-2020)
Table 65. Asia Pacific DTaP and Tdap Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 66. Asia Pacific DTaP and Tdap Vaccines Revenue Market Share by Region (2015-2020)
Table 67. Latin America DTaP and Tdap Vaccines Sales by Country (2015-2020) (K Units)
Table 68. Latin America DTaP and Tdap Vaccines Sales Market Share by Country (2015-2020)
Table 69. Latin Americaa DTaP and Tdap Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 70. Latin America DTaP and Tdap Vaccines Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa DTaP and Tdap Vaccines Sales by Country (2015-2020) (K Units)
Table 72. Middle East and Africa DTaP and Tdap Vaccines Sales Market Share by Country (2015-2020)
Table 73. Middle East and Africa DTaP and Tdap Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 74. Middle East and Africa DTaP and Tdap Vaccines Revenue Market Share by Country (2015-2020)
Table 75. Sanofi Pasteur Corporation Information
Table 76. Sanofi Pasteur Description and Business Overview
Table 77. Sanofi Pasteur DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Sanofi Pasteur DTaP and Tdap Vaccines Product
Table 79. Sanofi Pasteur Recent Development
Table 80. GlaxoSmithKline Corporation Information
Table 81. GlaxoSmithKline Description and Business Overview
Table 82. GlaxoSmithKline DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. GlaxoSmithKline Product
Table 84. GlaxoSmithKline Recent Development
Table 85. Protein Sciences Corporation Corporation Information
Table 86. Protein Sciences Corporation Description and Business Overview
Table 87. Protein Sciences Corporation DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Protein Sciences Corporation Product
Table 89. Protein Sciences Corporation Recent Development
Table 90. Novartis AG Corporation Information
Table 91. Novartis AG Description and Business Overview
Table 92. Novartis AG DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Novartis AG Product
Table 94. Novartis AG Recent Development
Table 95. Seqirus Corporation Information
Table 96. Seqirus Description and Business Overview
Table 97. Seqirus DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Seqirus Product
Table 99. Seqirus Recent Development
Table 100. Merck Sharp & Dohme Corp Corporation Information
Table 101. Merck Sharp & Dohme Corp Description and Business Overview
Table 102. Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Merck Sharp & Dohme Corp Product
Table 104. Merck Sharp & Dohme Corp Recent Development
Table 105. Astellas Pharma US, Inc Corporation Information
Table 106. Astellas Pharma US, Inc Description and Business Overview
Table 107. Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Astellas Pharma US, Inc Product
Table 109. Astellas Pharma US, Inc Recent Development
Table 110. Pfizer Inc Corporation Information
Table 111. Pfizer Inc Description and Business Overview
Table 112. Pfizer Inc DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Pfizer Inc Product
Table 114. Pfizer Inc Recent Development
Table 115. Johnson & Johnson Corporation Information
Table 116. Johnson & Johnson Description and Business Overview
Table 117. Johnson & Johnson DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Johnson & Johnson Product
Table 119. Johnson & Johnson Recent Development
Table 120. Lanzhou Institute of Biological Products Co., Ltd Corporation Information
Table 121. Lanzhou Institute of Biological Products Co., Ltd Description and Business Overview
Table 122. Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Lanzhou Institute of Biological Products Co., Ltd Product
Table 124. Lanzhou Institute of Biological Products Co., Ltd Recent Development
Table 125. AstraZeneca Corporation Information
Table 126. AstraZeneca Description and Business Overview
Table 127. AstraZeneca DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. AstraZeneca Product
Table 129. AstraZeneca Recent Development
Table 130. Emergent BioSolutions Inc Corporation Information
Table 131. Emergent BioSolutions Inc Description and Business Overview
Table 132. Emergent BioSolutions Inc DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Emergent BioSolutions Inc Product
Table 134. Emergent BioSolutions Inc Recent Development
Table 135. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 136. Key Challenges
Table 137. Market Risks
Table 138. Main Points Interviewed from Key DTaP and Tdap Vaccines Players
Table 139. DTaP and Tdap Vaccines Customers List
Table 140. DTaP and Tdap Vaccines Distributors List
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. DTaP and Tdap Vaccines Product Picture
Figure 2. Global DTaP and Tdap Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. DTaP Product Picture
Figure 4. Td Product Picture
Figure 5. Tdap Product Picture
Figure 6. Global DTaP and Tdap Vaccines Sales Market Share by Application in 2020 & 2026
Figure 7. Adult
Figure 8. Pediatric
Figure 9. DTaP and Tdap Vaccines Report Years Considered
Figure 10. Global DTaP and Tdap Vaccines Market Size 2015-2026 (US$ Million)
Figure 11. Global DTaP and Tdap Vaccines Sales 2015-2026 (K Units)
Figure 12. Global DTaP and Tdap Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global DTaP and Tdap Vaccines Sales Market Share by Region (2015-2020)
Figure 14. Global DTaP and Tdap Vaccines Sales Market Share by Region in 2019
Figure 15. Global DTaP and Tdap Vaccines Revenue Market Share by Region (2015-2020)
Figure 16. Global DTaP and Tdap Vaccines Revenue Market Share by Region in 2019
Figure 17. Global DTaP and Tdap Vaccines Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by DTaP and Tdap Vaccines Revenue in 2019
Figure 19. DTaP and Tdap Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global DTaP and Tdap Vaccines Sales Market Share by Type (2015-2020)
Figure 21. Global DTaP and Tdap Vaccines Sales Market Share by Type in 2019
Figure 22. Global DTaP and Tdap Vaccines Revenue Market Share by Type (2015-2020)
Figure 23. Global DTaP and Tdap Vaccines Revenue Market Share by Type in 2019
Figure 24. Global DTaP and Tdap Vaccines Market Share by Price Range (2015-2020)
Figure 25. Global DTaP and Tdap Vaccines Sales Market Share by Application (2015-2020)
Figure 26. Global DTaP and Tdap Vaccines Sales Market Share by Application in 2019
Figure 27. Global DTaP and Tdap Vaccines Revenue Market Share by Application (2015-2020)
Figure 28. Global DTaP and Tdap Vaccines Revenue Market Share by Application in 2019
Figure 29. China DTaP and Tdap Vaccines Sales Growth Rate 2015-2026 (K Units)
Figure 30. China DTaP and Tdap Vaccines Revenue Growth Rate 2015-2026 (US$ Million)
Figure 31. China DTaP and Tdap Vaccines Market Share in Global Market 2015-2026
Figure 32. China 5 and 10 Largest DTaP and Tdap Vaccines Players Market Share by Revenue in DTaP and Tdap Vaccines in 2019
Figure 33. China DTaP and Tdap Vaccines Revenue Share by Type (2015-2020)
Figure 34. China DTaP and Tdap Vaccines Revenue Growth Rate by Type in 2015 & 2019
Figure 35. China DTaP and Tdap Vaccines Revenue Share by Application (2015-2020)
Figure 36. China DTaP and Tdap Vaccines Revenue Growth Rate by Application in 2015 & 2019
Figure 37. North America DTaP and Tdap Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 38. North America DTaP and Tdap Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 39. North America DTaP and Tdap Vaccines Sales Market Share by Country in 2019
Figure 40. North America DTaP and Tdap Vaccines Revenue Market Share by Country in 2019
Figure 41. U.S. DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 42. U.S. DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Canada DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 44. Canada DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Europe DTaP and Tdap Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 46. Europe DTaP and Tdap Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe DTaP and Tdap Vaccines Sales Market Share by Country in 2019
Figure 48. Europe DTaP and Tdap Vaccines Revenue Market Share by Country in 2019
Figure 49. Germany DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 50. Germany DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 52. France DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 54. U.K. DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 56. Italy DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 58. Russia DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Asia Pacific DTaP and Tdap Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 60. Asia Pacific DTaP and Tdap Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific DTaP and Tdap Vaccines Sales Market Share by Region in 2019
Figure 62. Asia Pacific DTaP and Tdap Vaccines Revenue Market Share by Region in 2019
Figure 63. China DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 64. China DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 66. Japan DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 68. South Korea DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 70. India DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 72. Australia DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 74. Taiwan DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 76. Indonesia DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 78. Thailand DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 80. Malaysia DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 82. Philippines DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 84. Vietnam DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Latin America DTaP and Tdap Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America DTaP and Tdap Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America DTaP and Tdap Vaccines Sales Market Share by Country in 2019
Figure 88. Latin America DTaP and Tdap Vaccines Revenue Market Share by Country in 2019
Figure 89. Mexico DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 90. Mexico DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 92. Brazil DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 94. Argentina DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Middle East and Africa DTaP and Tdap Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa DTaP and Tdap Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa DTaP and Tdap Vaccines Sales Market Share by Country in 2019
Figure 98. Middle East and Africa DTaP and Tdap Vaccines Revenue Market Share by Country in 2019
Figure 99. Turkey DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Porter's Five Forces Analysis
Figure 106. DTaP and Tdap Vaccines Value Chain
Figure 107. Channels of Distribution
Figure 108. Distributors Profiles
Figure 109. Bottom-up and Top-down Approaches for This Report
Figure 110. Data Triangulation
Figure 111. Key Executives Interviewed